Personalised Cell Therapy
Hair follicles contain dermal papilla (DP) cells that control hair growth.
More DP cells = thicker hairs.
Research demonstrates that injecting DP cells into the skin can make thinning hairs thicker. HairClone has developed a clinical-grade process aimed at making this a reality for the treatment of androgenic alopecia. The treatment is currently undergoing early clinical testing.
HairClone can grow millions of dermal papilla cells from only a small number of hair follicles. Cells are injected into thinning regions with the aim of reprogramming miniaturising follicles into non-miniaturising ones to irreversibly thicken hair.
Hairclone's Innovative Approach
HairClone's revolutionary new treatment aims to maintain hair density throughout life.
HairClone’s approach of follicle rejuvenation treats hairs as they actively miniaturise and has the potential to prevent further hair loss.
Partnering with the Schambach Hair Clinic in Guatemala has allowed HairClone to begin clinically evaluating the response to this treatment and optimise it based on ongoing results.
